Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort.

IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Annals of Internal Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-03 DOI:10.7326/M24-0123
Diana L Miglioretti, Linn Abraham, Brian L Sprague, Christoph I Lee, Michael C S Bissell, Thao-Quyen H Ho, Erin J A Bowles, Louise M Henderson, Rebecca A Hubbard, Anna N A Tosteson, Karla Kerlikowske
{"title":"Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort.","authors":"Diana L Miglioretti, Linn Abraham, Brian L Sprague, Christoph I Lee, Michael C S Bissell, Thao-Quyen H Ho, Erin J A Bowles, Louise M Henderson, Rebecca A Hubbard, Anna N A Tosteson, Karla Kerlikowske","doi":"10.7326/M24-0123","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>False-positive results on screening mammography may affect women's willingness to return for future screening.</p><p><strong>Objective: </strong>To evaluate the association between screening mammography results and the probability of subsequent screening.</p><p><strong>Design: </strong>Cohort study.</p><p><strong>Setting: </strong>177 facilities participating in the Breast Cancer Surveillance Consortium (BCSC).</p><p><strong>Patients: </strong>3 529 825 screening mammograms (3 184 482 true negatives and 345 343 false positives) performed from 2005 to 2017 among 1 053 672 women aged 40 to 73 years without a breast cancer diagnosis.</p><p><strong>Measurements: </strong>Mammography results (true-negative result or false-positive recall with a recommendation for immediate additional imaging only, short-interval follow-up, or biopsy) from 1 or 2 screening mammograms. Absolute differences in the probability of returning for screening within 9 to 30 months of false-positive versus true-negative screening results were estimated, adjusting for race, ethnicity, age, time since last mammogram, BCSC registry, and clustering within women and facilities.</p><p><strong>Results: </strong>Women were more likely to return after a true-negative result (76.9% [95% CI, 75.1% to 78.6%]) than after a false-positive recall for additional imaging only (adjusted absolute difference, -1.9 percentage points [CI, -3.1 to -0.7 percentage points]), short-interval follow-up (-15.9 percentage points [CI, -19.7 to -12.0 percentage points]), or biopsy (-10.0 percentage points [CI, -14.2 to -5.9 percentage points]). Asian and Hispanic/Latinx women had the largest decreases in the probability of returning after a false positive with a recommendation for short-interval follow-up (-20 to -25 percentage points) or biopsy (-13 to -14 percentage points) versus a true negative. Among women with 2 screening mammograms within 5 years, a false-positive result on the second was associated with a decreased probability of returning for a third regardless of the first screening result.</p><p><strong>Limitation: </strong>Women could receive care at non-BCSC facilities.</p><p><strong>Conclusion: </strong>Women were less likely to return to screening after false-positive mammography results, especially with recommendations for short-interval follow-up or biopsy, raising concerns about continued participation in routine screening among these women at increased breast cancer risk.</p><p><strong>Primary funding source: </strong>National Cancer Institute.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7326/M24-0123","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: False-positive results on screening mammography may affect women's willingness to return for future screening.

Objective: To evaluate the association between screening mammography results and the probability of subsequent screening.

Design: Cohort study.

Setting: 177 facilities participating in the Breast Cancer Surveillance Consortium (BCSC).

Patients: 3 529 825 screening mammograms (3 184 482 true negatives and 345 343 false positives) performed from 2005 to 2017 among 1 053 672 women aged 40 to 73 years without a breast cancer diagnosis.

Measurements: Mammography results (true-negative result or false-positive recall with a recommendation for immediate additional imaging only, short-interval follow-up, or biopsy) from 1 or 2 screening mammograms. Absolute differences in the probability of returning for screening within 9 to 30 months of false-positive versus true-negative screening results were estimated, adjusting for race, ethnicity, age, time since last mammogram, BCSC registry, and clustering within women and facilities.

Results: Women were more likely to return after a true-negative result (76.9% [95% CI, 75.1% to 78.6%]) than after a false-positive recall for additional imaging only (adjusted absolute difference, -1.9 percentage points [CI, -3.1 to -0.7 percentage points]), short-interval follow-up (-15.9 percentage points [CI, -19.7 to -12.0 percentage points]), or biopsy (-10.0 percentage points [CI, -14.2 to -5.9 percentage points]). Asian and Hispanic/Latinx women had the largest decreases in the probability of returning after a false positive with a recommendation for short-interval follow-up (-20 to -25 percentage points) or biopsy (-13 to -14 percentage points) versus a true negative. Among women with 2 screening mammograms within 5 years, a false-positive result on the second was associated with a decreased probability of returning for a third regardless of the first screening result.

Limitation: Women could receive care at non-BCSC facilities.

Conclusion: Women were less likely to return to screening after false-positive mammography results, especially with recommendations for short-interval follow-up or biopsy, raising concerns about continued participation in routine screening among these women at increased breast cancer risk.

Primary funding source: National Cancer Institute.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乳腺癌监测联盟队列中假阳性结果与重新接受乳腺 X 线照相术筛查之间的关系。
背景:乳腺放射摄影筛查的假阳性结果可能会影响妇女今后再次接受筛查的意愿:评估乳腺放射摄影筛查结果与后续筛查概率之间的关联:设计:队列研究:177家参与乳腺癌监测联盟(BCSC)的机构:2005年至2017年期间,在1 053 672名40至73岁未确诊乳腺癌的女性中进行了3 529 825次乳腺X光筛查(3 184 482次真阴性和345 343次假阳性):1次或2次乳腺X光筛查结果(真阴性结果或假阳性召回,建议仅立即进行额外成像、短期随访或活检)。在对种族、民族、年龄、上次乳房 X 光检查后的时间、BCSC 登记以及妇女和机构内的聚类进行调整后,估计了假阳性筛查结果与真阴性筛查结果在 9 至 30 个月内重返筛查的概率的绝对差异:妇女在筛查结果为真阴性(76.9% [95% CI,75.1% 至 78.6%])后复查的可能性高于在筛查结果为假阳性后复查的可能性,前者只需进行额外的影像学检查(调整后绝对差异为-1.9 个百分点 [CI,-3.1 至 -0.7 个百分点]),后者只需进行短期随访(-15.9 个百分点 [CI,-19.7 至 -12.0 个百分点])或活检(-10.0 个百分点 [CI,-14.2 至 -5.9 个百分点])。与真阴性相比,亚裔和西班牙裔/拉丁裔妇女在出现假阳性后被建议进行短期随访(-20 到-25 个百分点)或活检(-13 到-14 个百分点)的概率下降幅度最大。在5年内接受过2次乳房X光筛查的妇女中,无论第一次筛查结果如何,第二次筛查的假阳性结果与第三次筛查的复查概率降低有关:局限性:妇女可能在非BCSC机构接受治疗:结论:女性在乳腺X光检查结果呈假阳性后再次接受筛查的可能性较低,尤其是在建议短期随访或活检的情况下,这引起了人们对这些乳腺癌风险较高的女性继续参与常规筛查的担忧:国家癌症研究所。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of Internal Medicine
Annals of Internal Medicine 医学-医学:内科
CiteScore
23.90
自引率
1.80%
发文量
1136
审稿时长
3-8 weeks
期刊介绍: Established in 1927 by the American College of Physicians (ACP), Annals of Internal Medicine is the premier internal medicine journal. Annals of Internal Medicine’s mission is to promote excellence in medicine, enable physicians and other health care professionals to be well informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. To achieve this mission, the journal publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine.
期刊最新文献
In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4. In symptomatic knee OA, adding oral methotrexate to usual analgesia reduced pain at 6 mo. In T2D, SGLT-2 inhibitor effects on CV and kidney outcomes were consistent regardless of GLP-1 receptor agonist use. Patient Travel Patterns and Concordance With Geographic Market Boundaries. Patients surviving COVID-19 had lower risk for long COVID in the Omicron vs. earlier eras.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1